These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18405840)

  • 1. Assessing drug-likeness--what are we missing?
    Vistoli G; Pedretti A; Testa B
    Drug Discov Today; 2008 Apr; 13(7-8):285-94. PubMed ID: 18405840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries.
    Dobson PD; Patel Y; Kell DB
    Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular properties that influence oral drug-like behavior.
    Lajiness MS; Vieth M; Erickson J
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):470-7. PubMed ID: 15338956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guiding molecules towards drug-likeness.
    Egan WJ; Walters WP; Murcko MA
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemodiversity and molecular plasticity: recognition processes as explored by property spaces.
    Vistoli G; Pedretti A; Testa B
    Future Med Chem; 2011 Jun; 3(8):995-1010. PubMed ID: 21707401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL; Montanari CA; Andricopulo AD
    Bioorg Med Chem; 2007 Dec; 15(24):7738-45. PubMed ID: 17870541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
    Wang J; Krudy G; Xie XQ; Wu C; Holland G
    J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead optimization in the nondrug-like space.
    Zhao H
    Drug Discov Today; 2011 Feb; 16(3-4):158-63. PubMed ID: 21147254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure.
    Leach AG; Jones HD; Cosgrove DA; Kenny PW; Ruston L; MacFaul P; Wood JM; Colclough N; Law B
    J Med Chem; 2006 Nov; 49(23):6672-82. PubMed ID: 17154498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex molecules: do they add value?
    Selzer P; Roth HJ; Ertl P; Schuffenhauer A
    Curr Opin Chem Biol; 2005 Jun; 9(3):310-6. PubMed ID: 15939334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond profiling: using ADMET models to guide decisions.
    Segall M; Champness E; Obrezanova O; Leeding C
    Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stereochemistry and drug effects--a neglected field of knowledge].
    Reis M; Kugelberg FC; Carlsson B; Josefsson M; Waldeck B
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1305-6, 1309-11. PubMed ID: 16708858
    [No Abstract]   [Full Text] [Related]  

  • 17. Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2008 Apr; 48(4):797-810. PubMed ID: 18393490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distance phenomena in high-dimensional chemical descriptor spaces: consequences for similarity-based approaches.
    Rupp M; Schneider P; Schneider G
    J Comput Chem; 2009 Nov; 30(14):2285-96. PubMed ID: 19266481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.